Prejunctional actions of N-ethyl-maleimide and phenoxybenzamine in rat vas deferens

I Browne1, G Thomas, K Gavin

  • 1Department of Physiology, Royal College of Surgeons, Ireland, Dublin.

Insights

N-ethyl-maleimide affects prejunctional receptors in rat vas deferens by mechanisms beyond G-protein inactivation, as shown by its distinct effects compared to alpha 2-adrenoceptor antagonists.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Physiology

Background:

  • Prejunctional receptors modulate neurotransmitter release.
  • Alpha-2 adrenoceptors and serotonin receptors play roles in regulating smooth muscle contraction.
  • N-ethyl-maleimide is a chemical agent used to probe protein function.

Purpose of the Study:

  • To investigate the mechanism of action of N-ethyl-maleimide on prejunctional inhibitory receptors.
  • To differentiate the effects of N-ethyl-maleimide from known alpha-2 adrenoceptor antagonists.

Main Methods:

  • Electrically evoked isometric contractions of rat vas deferens.
  • Pretreatment with N-ethyl-maleimide, phenoxybenzamine, or EEDQ.
  • Receptor binding assays using [3H]MK 912.

Main Results:

  • N-ethyl-maleimide reduced the potency of xylazine and 5-hydroxytryptamine but not amidephrine.
  • Phenoxybenzamine and EEDQ altered xylazine's effects, but N-ethyl-maleimide did not further modify these.
  • N-ethyl-maleimide did not bind to alpha-2 adrenoceptors at effective concentrations.

Conclusions:

  • N-ethyl-maleimide's effects on prejunctional receptors may involve mechanisms other than direct G-protein inactivation.
  • The findings suggest a complex interplay between N-ethyl-maleimide, G-proteins, and alpha-2 adrenoceptors.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...